| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SURF | Surface Oncology, Inc. | Lilly Ventures Fund I LLC | 10% Owner | Apr 23, 2018 | Buy | $15.00 | 266,000 | 3,990,000 | 3,447,817 | Apr 23, 2018, 04:16 PM | |
| ALRN | AILERON THERAPEUTICS INC | Lilly Ventures Fund I LLC | Former 10% owner | Jul 05, 2017 | Buy | $15.00 | 250,000 | 3,750,000 | 1,094,987 | Jul 07, 2017, 07:16 PM | |
| PTGX | Protagonist Therapeutics, Inc | Lilly Ventures Fund I LLC | 10% Owner | Aug 16, 2016 | Buy | $12.00 | 583,333 | 6,999,996 | 2,099,482 | Aug 16, 2016, 06:19 PM | |
| CHRS | Coherus BioSciences, Inc. | Lilly Ventures Fund I LLC | Former 10% Owner | Nov 12, 2014 | Buy | $13.50 | 164,963 | 2,227,001 | 3,042,019 | Nov 12, 2014, 11:50 AM | |
| CERU | Cerulean Pharma Inc. | Lilly Ventures Fund I LLC | 10% Owner | Apr 15, 2014 | Buy | $7.00 | 733,445 | 5,134,115 | 2,356,227 | Apr 15, 2014, 08:41 PM | |
| RCPT | Receptos, Inc. | Lilly Ventures Fund I LLC | 10% Owner | May 14, 2013 | Buy | $6.73 | 1,966,925 | 13,242,987 | 2,081,210 | Nov 21, 2013, 05:23 PM | |
| RCPT | Receptos, Inc. | Lilly Ventures Fund I LLC | 10% Owner | May 14, 2013 | Option Exercise | $6.73 | 1,966,925 | 13,242,987 | 2,081,210 | May 14, 2013, 05:34 PM |
Menu